MAGELLAN LONGEVITY
HomeResearchStudy library › Glycine and N-Acetylcysteine (GlyNAC) supplementation in older…
Study summary · Immunity, inflammation & resilience

Can GlyNAC supplementation improve glutathione deficiency, oxidative stress, mitochondrial dysfunction, insulin resistance, physical function, and aging hallmarks in older adults?

In one paragraph

GlyNAC, a randomized controlled trial in 24 older adults (The Journals of Gerontology: Series A 2022, PMID 35975308) — glyNAC supplementation in older adults for 16 weeks improved or corrected these defects, while the placebo did not. Scope: 24 older adults, over 16 weeks, and the abstract states no limitations.

Source: The Journals of Gerontology: Series A 2022, PMID 35975308 ↗ · Research map · How Magellan grades evidence · evidence confidence: medium

The Journals of Gerontology: Series A · 2022 · PMID 35975308

Plain-English summary written and published by Magellan Longevity · medical review by Gabriel Radu, DO (physiatrist, NPI 1376861765). We summarize what the paper reported — we did not run this study.

Magellan holds two summaries of this same paper (PMID 35975308). The primary, canonical version is Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults Improves….
The takeaway

GlyNAC supplementation in older adults can reverse several age-related health declines, including oxidative stress and mitochondrial dysfunction.

The question

Can GlyNAC supplementation improve glutathione deficiency, oxidative stress, mitochondrial dysfunction, insulin resistance, physical function, and aging hallmarks in older adults?

What they tested

GlyNAC supplementation in older adults will improve glutathione deficiency, oxidative stress, mitochondrial dysfunction, insulin resistance, physical function, and aging hallmarks, similar to observations in aged mice.

How they did it

A placebo-controlled randomized clinical trial was conducted with 24 older adults (OA) and 12 young adults (YA). OA were randomized to receive either GlyNAC (N=12) or an isonitrogenous alanine placebo (N=12) for 16 weeks. YA (N=12) received GlyNAC for 2 weeks. Participants were assessed at baseline, 2 weeks, and 16 weeks for various markers including GSH concentrations, oxidative stress, mitochondrial function, inflammation, insulin resistance, physical function, and aging hallmarks.

What they found

Compared to young adults, older adults exhibited glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, multiple aging hallmarks, and impaired physical function. GlyNAC supplementation in older adults for 16 weeks improved or corrected these defects, while the placebo did not. GlyNAC was safe and well-tolerated.

What it means

GlyNAC supplementation in older adults is an effective nutritional supplement that improves and reverses multiple age-associated abnormalities, including glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, and impaired physical function, thereby promoting health in aging humans.

Limitations

The abstract does not explicitly state any limitations of the study.

Where the published abstract does not list limitations, we say so rather than inventing them. Read the full paper on PubMed before drawing conclusions.

“GlyNAC supplementation improved glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, physical function and multiple hallmarks of aging in older adults.”— from the published abstract, The Journals of Gerontology: Series A 2022

The paper at a glance

TitleGlycine and N-Acetylcysteine (GlyNAC) supplementation in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, physical function, and aging hallmarks: A randomized clinical trial
JournalThe Journals of Gerontology: Series A
Year2022
PMID35975308 ↗
TopicImmunity, inflammation & resilience
DOINot recorded in our database — use the PubMed record above.

Read the source: PubMed record (authors, abstract, full citation) ↗

Where Magellan uses this paper

This citation sits behind the evidence grade on the pages below. Grades are set from the research and are independent of affiliate commissions.

GlyNAC (Glycine + N-Acetylcysteine)

In small clinical trials, mostly pilot and open-label studies plus one randomized placebo-controlled trial of 24 older adults from the same laboratory, GlyNAC supplementation corrected glutathione deficiency and improved markers of oxidative stress, mitochondrial function, inflammation, insulin resistance, muscle…

GlyNAC (Glycine + NAC)

GlyNAC is a nutritional supplement combining two amino acids, glycine and N-acetylcysteine (NAC, a…

Check price on Amazon ↗

Research describes the compound or intervention studied. It is not a claim about any specific product.

Molecules & mechanisms in this paper

Each of these is named in the paper’s own words above. Open the monograph for the full mechanism and its other citations.

Cite this page

These citations point at this summary. To cite the original paper with its full author list, use the PubMed record.

APA
Magellan Longevity. (2026). Can GlyNAC supplementation improve glutathione deficiency, oxidative stress, mitochondrial dysfunction, insulin resistance, physical function, and aging hallmarks in older adults? [Plain-English summary of The Journals of Gerontology: Series A 2022, PMID 35975308]. Magellan Longevity. https://magellanlongevity.com/study/glutathione_glynac.html
BibTeX
@misc{magellan_glynac_rct, title = {Can GlyNAC supplementation improve glutathione deficiency, oxidative stress, mitochondrial dysfunction, insulin resistance, physical function, and aging hallmarks in older adults?}, author = {{Magellan Longevity}}, year = {2026}, howpublished = {\url{https://magellanlongevity.com/study/glutathione_glynac.html}}, note = {Plain-English summary of PubMed PMID 35975308; The Journals of Gerontology: Series A 2022. Reviewed by Gabriel Radu, DO}, urldate = {2026-08-11} }
Permalink
https://magellanlongevity.com/study/glutathione_glynac.html

Related studies in the Magellan library

All 17 Magellan summaries on immunity, inflammation & resilience →

How this summary was made. Every section above restates what the published abstract of PMID 35975308 reports — the question, the design, the numbers, the authors’ own conclusion and their stated limitations. We do not add claims the paper did not make, and we keep negative and no-effect findings in. Magellan’s evidence grades are set from research like this and never from affiliate commissions.

Prefer the interactive version? Open this summary in the Magellan app → · Browse all 314 study summaries →

Educational information, not medical advice. This is a plain-English summary of published research; it is not a treatment recommendation and nothing here is intended to diagnose, treat, cure, or prevent any disease. Individual studies can be wrong, and a single paper rarely settles a question. Talk to your physician before acting on any research, especially if you are pregnant, nursing, or taking medication.